Literature DB >> 23245354

Contraception counseling, pregnancy intention and contraception use in women with medical problems: an analysis of data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS).

Jamila B Perritt1, Anne Burke, Roxanne Jamshidli, Jiangxia Wang, Michelle Fox.   

Abstract

BACKGROUND: Data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS) were used to evaluate whether women with selected medical comorbidities are less likely than healthier women to report receiving contraceptive counseling during pregnancy and to report using contraception postpartum.
METHODS: We analyzed de-identified data from the 2004-2007 Maryland PRAMS using logistic regression to evaluate these outcomes: undesired pregnancy, self-reported antepartum contraceptive counseling and postpartum contraceptive use for women with and without hypertension, diabetes or heart disease. Survey data were used to estimate response frequency within the Maryland birth population.
RESULTS: Patient self-report of contraceptive use increased overall during the postpartum period as compared to the antepartum period, from 44.3%-90.1% (p<.001). Almost one fourth (23%) of 6361 respondents reported receiving no contraceptive counseling. There was no difference in reported contraceptive counseling in women with selected medical comorbidities as compared to those without, and only women with preconception diabetes mellitus were significantly less likely than healthier women to report postpartum contraceptive use.
CONCLUSIONS: Overall, there was no difference in the report of receiving contraceptive counseling in women with selected medical comorbidities as compared to than those without. In addition, they were not more likely to report receiving contraceptive counseling either despite higher risk of pregnancy complications. These results indicate lost opportunities for effective counseling that could improve health outcomes.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contraception; Medical comorbidities; PRAMS; Pregnancy Risk Assessment Monitoring System: Contraceptive counseling

Mesh:

Year:  2012        PMID: 23245354     DOI: 10.1016/j.contraception.2012.11.009

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

1.  Interdelivery Interval and Diabetes Mellitus in a Subsequent Pregnancy.

Authors:  Annie M Dude; Ashley Battarbee; Lynn M Yee
Journal:  Am J Perinatol       Date:  2018-11-30       Impact factor: 1.862

2.  Operationalizing and Examining Family Planning Vigilance in Adult Women With Type 1 Diabetes.

Authors:  Susan M Sereika; Dorothy Becker; Patricia Schmitt; A Blair Powell; Ana Maria Diaz; Andrea F R Fischl; Jennifer Thurheimer-Cacciotti; William H Herman; Denise Charron-Prochownik
Journal:  Diabetes Care       Date:  2016-10-11       Impact factor: 19.112

3.  Documented contraceptive use after delivery in women with pre-gestational and gestational diabetes in Thailand: a single center study.

Authors:  Raksina Winaitammakul; Preeyaporn Jirakittidul; Nichamon Pingkul
Journal:  Diabetol Int       Date:  2022-05-26

4.  Pattern of contraceptive use among reproductive-aged women with diabetes and/or hypertension: findings from Bangladesh Demographic and Health Survey.

Authors:  Md Nuruzzaman Khan; M Mofizul Islam; Rakibul M Islam
Journal:  BMC Womens Health       Date:  2022-06-15       Impact factor: 2.742

5.  Chronic Diseases and Use of Contraception Among Women at Risk of Unintended Pregnancy.

Authors:  Ghasi S Phillips-Bell; William Sappenfield; Cheryl L Robbins; Leticia Hernandez
Journal:  J Womens Health (Larchmt)       Date:  2016-06-13       Impact factor: 2.681

6.  Perceptions and Behaviors Related to Contraceptive Use in the Postpartum Period Among Women With Pregestational Diabetes Mellitus.

Authors:  Laura E Britton; Diane C Berry; Jamie L Crandell; Jada L Brooks; Amy G Bryant
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2020-01-14

7.  Preconception Counseling, Contraceptive Counseling, and Long-Acting Reversible Contraception Use in Women with Type I Diabetes: A Retrospective Cohort Study.

Authors:  Elizabeth A Disney; Jessica N Sanders; David K Turok; Lori M Gawron
Journal:  Womens Health Rep (New Rochelle)       Date:  2020-09-09

8.  Patterns of contraceptive use among young Australian women with chronic disease: findings from a prospective cohort study.

Authors:  Melissa L Harris; Nicholas Egan; Peta M Forder; Deborah Bateson; Aaron L Sverdlov; Vanessa E Murphy; Deborah Loxton
Journal:  Reprod Health       Date:  2022-05-07       Impact factor: 3.355

Review 9.  Knowledge gaps in reproductive and sexual health in girls and women with sickle cell disease.

Authors:  Lydia H Pecker; Deva Sharma; Alecia Nero; Michael J Paidas; Russell E Ware; Andra H James; Kim Smith-Whitley
Journal:  Br J Haematol       Date:  2021-07-07       Impact factor: 8.615

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.